C

쓰리빌리언

394800KOSDAQ자연과학 및 공학 연구개발업

49.3 / 100

Reference Date: 2026-06-10

Financial Score14.0 / 40
News Sentiment21.3 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR raises overvaluation concerns, ROE is below the industry average. Plunged 38.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

3billion is a company leading the diagnosis and development of treatments for rare diseases using AI-based genome interpretation technology, offering genetic testing services such as whole genome and whole exome sequencing. As of 2025, it generates revenue in 75 countries, with 67.4% of sales coming from overseas, and has launched its own genetic variant interpretation software 'GEBRA' as a SaaS product.

Number of Employees

196people

Average Salary

67.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 62.704.0Point
PBR
9.84Industry Average 3.240.0Point

3.0x industry avg (risky)

ROE
-20.87Industry Average -32.093.5Point

Below industry avg

Debt Ratio
11.50Industry Average 7.310.5Point

1.6x industry avg (risky)

Trend 2024~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲102.8% (1-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲20.6% (1-year basis)

ROE Trend
0.0 / 4

Avg ROE -26.8% (improving, 2yr)

Detailed News Sentiment

6 totalPositive 6Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 7,300Won52-week high 18,80052-week low 5,600
1-month return0.0Point

1m -37.98% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-26
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-26
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-26
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-26
  • Neutral주식등의대량보유상황보고서(일반)2026-05-26